Clinical Trial Update: Phase II Clinical Study of Vonorasan Fumarate Injection in the Treatment of Peptic Ulcer Bleeding [Phase 2]

View source ↗

Summary

A Phase II clinical study of Vonorasan Fumarate Injection for Peptic Ulcer Bleeding has not yet begun recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Bleeding

Drugs mentioned

• Vonorasan Fumarate Injection (Vonorasan Fumarate)

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Peptic Ulcer Bleeding | Phase 2 | Status: NOT_YET_RECRUITING